# Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/erlotinib-versus-gemcitabine-plus-cisplatin-as-neoadjuvant-treatment-of-stage/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Wen‐Zhao Zhong,Ke‐Neng Chen,Chun Chen,Chundong Gu,Jun Wang,Xue‐Ning Yang,Weimin Mao,Qun Wang,Guibin Qiao,Ying Cheng,Lin Xu,Changli Wang,Mingwei Chen,Xiaozheng Kang,Wanpu Yan,Hong‐Hong Yan,Ri-Qiang Liao,Jin‐Ji Yang,Xu‐Chao Zhang,Qing Zhou,Yi‐Long Wu |
| Citations | 268 |
| DOI | 10.1200/jco.19.00075 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2951872058 |
| PMID | 31194613 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Wen‐Zhao Zhong](https://scholariq.org/researchers/wen-zhao-zhong/)
- [Xu‐Chao Zhang](https://scholariq.org/researchers/xu-chao-zhang/)
- [Qing Zhou](https://scholariq.org/researchers/qing-zhou/)
- [Hong‐Hong Yan](https://scholariq.org/researchers/hong-hong-yan/)
- [Ying Cheng](https://scholariq.org/researchers/ying-cheng/)
- [Jin‐Ji Yang](https://scholariq.org/researchers/jin-ji-yang/)
- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.